Classification of WHO Essential Oral Medicines for Children Applying a Provisional Pediatric Biopharmaceutics Classification System

Podobne zapisy

• Biopharmaceutical optimization in neglected diseases for paediatric patients by applying the provisional paediatric biopharmaceutical classification system
  od: del Moral Sanchez, Jose Manuel, i wsp.
  Wydane: (2018)
• Availability of Authorizations from EMA and FDA for Age-Appropriate Medicines Contained in the WHO Essential Medicines List for Children 2019
  od: delMoral-Sanchez, Jose-Manuel, i wsp.
  Wydane: (2020)
• Global testing of a consensus solubility assessment to enhance robustness of the WHO biopharmaceutical classification system
  od: Valeria Gigante, i wsp.
  Wydane: (2020-10-01)
• Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development
  od: Wolk, Omri, i wsp.
  Wydane: (2014)
• Evaluation of the use of partition coefficients and molecular surface properties as predictors of drug absorption: a provisional biopharmaceutical classification of the list of national essential medicines of Pakistan
  od: Shawahna, R., i wsp.
  Wydane: (2011)